TrialCancer immunology, immunotherapy : CII2003

Durable complete clinical responses in a phase I/II trial using an autologous melanoma cell/dendritic cell vaccine.

Michael G E O'Rourke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.